Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanoink appoints James M. Hussey CEO

Abstract:
NanoInk, Inc. announced today the appointment of James M. Hussey, 48, as its Chief Executive Officer, as well as a member of its Board of Directors.

Nanoink appoints James M. Hussey CEO

SKOKIE, IL | Posted on January 22nd, 2008

Mr. Hussey joins NanoInk from Ovation Pharmaceuticals, Inc., a leading biopharmaceutical company where he served on the senior management team. Mr. Hussey will be a member of the external Advisory Board of Ovation and remain involved with the company. Mr. Hussey is also an angel investor and has been involved with or founded several early stage biotechnology companies including Silamed Pharmaceuticals, ProCor Pharmaceuticals and Barbeau Pharmaceuticals.

Prior to joining Ovation Pharmaceuticals, Mr. Hussey served as president and chief executive officer of NeoPharm, Inc., a biotechnology company specializing in the research, development and marketing of cancer drugs. Mr. Hussey also served as a director of Option Care, a local pharmacy infusion company, from 1999 until 2004.

Mr. Hussey began his career at Bristol-Myers Squibb in marketing, sales and new business development before being appointed to general manager in 1994. In 1995, he founded and served as chief executive officer of Physicians Quality Care, a physician management services organization in Oak Brook, Ill. which was sold in 1998.

Mr. Hussey received a B.S. degree in Pharmacy from Butler University and a Master of Business Administration degree from University of Illinois at Chicago. He currently serves on the Board of the Illinois Biotechnology Organization.

"We are delighted to have Jim lead the NanoInk team," said Mark Slezak, Chairman of the Company's Board of Directors. "He brings to us over two decades of executive management, product development and marketing leadership at both small and large pharmaceutical companies. His expertise and leadership will help drive NanoInk's growth in the future."

In accepting his appointment, Mr. Hussey said, "I am extremely excited about the opportunities of both Brand Protection and Dip Pen Nanolithography (DPN). NanoInk is a high quality organization with an extremely promising future."

####

About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries. With DPN, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.

For more information, please click here

Contacts:
David Gutierrez
Dresner Corporate Services
NanoInk
312-780-7204


Joshua Taustein
Dresner Corporate Services
NanoInk
312-780-7219

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Appointments/Promotions/New hires/Resignations/Deaths

The National Space Society Mourns the Passing of Robert Krone, Founder of the Kepler Space Institute: Krone's Visionary and Humanistic Approach to the Study of Space Communities and Settlement Was Unique September 22nd, 2021

Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021

JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021

The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project